The 2026 Tactical Email Playbook for Series A Healthtech Decision Makers: Steal These Sequences, Send From Origami

Quick Answer

You already have a list of Series A healthtech decision makers. Now you need to turn that list into conversations. Origami isn’t just a list-building tool — it has a built-in email sequencer that sends your multi-step campaigns, tracks replies, and automatically un-enrolls responders, all from the same dashboard where you built your prospect list. This guide walks through refining your list, writing a 3‑touch cold email sequence that speaks directly to healthtech founders and leaders in 2026, and launching everything without exporting a single CSV.

If you haven’t built a list yet, here’s how to find Series A Healthtech Decision Makers in Origami. But if you already have a healthy set of leads, let’s get them into a campaign that doesn’t feel like generic outreach.

---

Step 1: Build the List in Origami (If You Haven’t Already)

In 2026, finding Series A healthtech contacts manually means stitching together Crunchbase, LinkedIn Sales Navigator, Apollo, and a dozen other tools — then hoping enrichment doesn’t return outdated emails. Origami collapses that into a single prompt.

When you open Origami, you describe your ideal customer in plain English. For Series A healthtech decision makers, a prompt like this works:

"Find Series A healthtech startups in the US founded after 2020, with 25–200 employees. Give me the CEO, CTO, Head of Product, and VP of Engineering where possible. Include verified work emails, direct dials, and the company’s primary EHR integration partner if available."

Origami’s AI agent searches the live web, chains data sources, and returns a clean list with names, titles, email addresses, phone numbers, company details, and any tech-stack signals it can surface (e.g., FHIR adoption, cloud infrastructure). No manual enrichment. No bouncing between tabs.

If you’re new to Origami, the free plan includes 1,000 enrichment credits — no credit card required. That’s enough to build and verify 250–500 leads, depending on depth. Paid plans start at $29/month and give you the sequencer at no extra cost. You only pay for credits to enrich leads; the sending itself is free on all paid tiers.

---

Step 2: Refine and Qualify Your List

A raw list of 300 healthtech contacts looks promising, but you’ll waste sends if you don’t qualify beyond the basic filters. In Origami, after you generate the list, you can review each lead inline. Use the built-in tags and segmentation to clean it up before any email goes out.

What to Remove Immediately

• Pre-product or pre-revenue companies. Look at employee count and any funding signals. If the Series A closed 18+ months ago but the company still has <15 employees, they might be stuck — not an ideal buyer.
• Wrong role. A Chief Medical Officer at a virtual care company is relevant; a CMO at a wellness SaaS might not be. Read the title literally. Origami often surfaces additional role details that help you decide.
• Industries masquerading as healthtech. Some companies file under “healthtech” but are actually medical billing firms or fitness apps. Check the company description snippets Origami enriches.

How to Segment for Email Relevance

Healthtech isn’t a monolith. A CEO running a D2C mental health app has different priorities than a VP of Product at a diagnostics AI startup. Segment by:

• Company type: digital therapeutic, provider-facing workflow tool, payer-tech, remote patient monitoring, clinical trial SaaS, etc.
• Regulatory posture: FDA-cleared or 510(k)-exempt vs. purely wellness. The former cares about submission timelines; the latter cares about speed to market without regulatory friction.
• Buyer maturity: If they already have an EHR integration in production (visible via tech-stack signals), their pain is scaling it. If they don’t, their pain is avoiding a 9-month build.

What a Qualified Lead Looks Like for This Audience

A qualified Series A healthtech decision maker in 2026:

• Works at a company that has raised a Series A within the last 24 months (capital to spend).
• Holds a title that owns product, engineering, or growth (CEO, CTO, CPO, VP Product, VP Engineering, Head of Growth).
• Operates in a regulated or semi-regulated space where time-to-revenue is gated by integration, compliance, or clinical validation.
• Shows signals of active commercial motion: recent hires in sales or partnerships, partnership announcements, or pilot mentions in public releases.

Origami’s enrichment surfaces these signals — use them to build your segments in under 10 minutes. Once you have a segmented, qualified list of 150–200 contacts, you’re ready to write the sequence.

---

Step 3: Create the Email Sequence

In Origami, you have two ways to build your sequence:

1. Paste your own templates. You write the 3‑touch email copy yourself (or steal the templates below), paste them into the sequencer, set your delays (e.g., Day 1, Day 3, Day 7), and hit launch. Every message goes out with the exact wording you control, but Origami still personalizes placeholders like and automatically.

2. Let the agent write it. Tell Origami’s AI to generate a personalized 3‑day email sequence. It will craft different copy for each lead based on their title, company, industry, and any signal it has (like a recent FDA clearance or a job opening). The agent writes messages that sound like they were hand-researched, not mail-merged.

I recommend starting with pre-written templates you know work for your product, then later test the AI-generated versions against them. Below is a full 3‑touch sequence for Series A healthtech leaders — steal it, adapt it, and launch it today.

Day 1 — Initial Cold Email

Subject: scaling without the EHR headache 
Preview: quick question about ramping provider pilots

Hi ,

Most Series A healthtechs I speak with have a product that works beautifully in a sandbox — but the first enterprise pilot stalls because of EHR integration. Months of dev, compliance back-and-forth, and a risk-averse health system IT team.

We built to remove that bottleneck. We help healthtechs get from signed LOI to live patient data in under 30 days, fully HIPAA-compliant, with pre-built FHIR connectors for Epic, Cerner, and Meditech.

Curious if this could shorten your current pilot timeline?

Best,

Day 3 — Follow-Up (Different Angle)

Subject: the regulatory pathway most healthtechs overlook
Preview: how 2 digital therapeutics shortened theirs

Hi ,

Following up on my note — I know regulatory timelines are just as tight as technical ones for healthtechs in your space.

We’ve helped two digital therapeutics companies cut their Q-submission prep time by 40% because our integration layer was already audited against FDA’s cybersecurity and interoperability expectations. The pre-reviewed architecture meant they could point to a live deployable stack rather than start from scratch.

Would you like me to share a redacted project timeline from one of them? No pitch, just a concrete example.

Day 7 — Final Breakup

Subject: closing the loop re:
Preview: no more emails after this, promise

Hi ,

Tried a couple of different angles — if now isn’t the right time, no hard feelings.

In case it’s useful, I put together a short PDF on "5 EHR Integration Pitfalls Series A Healthtechs Make in 2026" — things like underestimating provider identity management and assuming FHIR means plug-and-play. No demo pitch inside.

Want me to send the PDF?

Thanks,

P.S. I’ll close the loop on my end, but if you’re ever rethinking your integration roadmap, I’m here.

---

Those are full messages you can copy, tweak, and own. The sequence works because each email introduces a distinct value prop (speed-to-pilot, regulatory shortcut, helpful resource) without repeating the opener. It feels like three separate attempts to be useful, not one idea hammered three times.

---

Step 4: Send the Sequence Directly From Origami

Once you’ve chosen your templates (or let the agent write the sequence), you don’t export anything. Origami’s built-in email sequencer handles the entire sending flow. Here’s what happens when you hit “Launch Campaign”:

• The sequence fires automatically. Day 1 email goes to all contacts in the campaign at the time you set (or staggered if you enable that). Day 3 and Day 7 follow based on the delay you configured.
• Live tracking in the same dashboard. Opens, clicks, and replies appear right next to the same enriched profile you used to qualify the lead. You can see that Jane, CTO at a remote monitoring company, opened twice and clicked your case study — and you can still see her company’s tech stack and headcount without switching windows.
• Automatic un-enrollment. If a lead replies, they exit the sequence immediately. No one gets the breakup message after they’ve already booked a meeting. This prevents the most embarrassing cold-email mistake and keeps your domain reputation clean.
• No CSV, no sync. From list-building to outreach, you stay in one platform. You found the leads, enriched them, segmented them, wrote the sequence, and sent it — all inside Origami. No separate sequencer tool, no integrations that break when you update a field.

The sequencer is included on all paid plans. You pay only for the credits used to enrich the leads; sending is free. If you’re on the free plan, you can test the sequencer with the 1,000 enrichment credits, but you’ll need a paid plan to keep sending to larger lists.

Response Rates and When to Iterate

For a well-targeted Series A healthtech audience, expect a 2–5% positive reply rate — that’s replies that ask for a meeting, express interest, or request the resource. A 2% rate from 200 contacts means 4 qualified conversations; at 5% it’s 10. In a market where enterprise sales cycles can run 6–12 months, those numbers can fully fill a founder’s pipeline.

If you’re below 2% after 400 sends, debug in this order:

1. List quality — Are you hitting the right titles? Is the company stage actually Series A? Bad list data kills response faster than anything.
2. Messaging — Are you addressing a concrete pain they feel this quarter? Swap the “EHR integration” angle for “clinical evidence generation” or “reimbursement strategy” depending on your segment.
3. Timing — Healthtech leaders attend JPMorgan in January, HIMSS in March, HLTH in October. Campaigns hitting during those weeks see lower reply rates because inboxes are flooded. Try two weeks after a major conference.

A/B test the AI-generated sequence against your templates after you have a baseline. Origami’s agent might uncover angles you hadn’t considered, and you can run split tests by cloning a campaign and sending each version to 100 contacts.

---

Quick Wrap-Up

You now have the exact sequence and the exact sending flow to turn a list of Series A healthtech decision makers into conversations — all from within Origami. The built-in sequencer means you never lose context between list-building and outreach, and you stop paying for separate email tools that don’t talk to your lead data.

If you need to go back and build a fresh list of Series A healthtech contacts, here’s the full guide to finding them with Origami. Otherwise, log in, paste the templates, and launch. Your first qualified reply could come in before the Day 3 follow-up even hits.